Purpose: To characterize retinal structure and function in achromatopsia (ACHM) in preparation for clinical trials of gene therapy.
Achromatopsia (ACHM) is a cone dysfunction syndrome with an incidence of approximately 1 in 30 000, which presents at birth or early infancy. 1 It is characterized by marked photophobia and nystagmus, reduced visual acuity (20/120 to 20/200), very poor or absent color vision, and absent cone electroretinogram responses, with normal rod function. Fundus examination is usually normal, although retinal pigment epithelial (RPE) disturbance and atrophy may be present. Mutations in 5 genes have been identified in ACHM: CNGA3, CNGB3, GNAT2, PDE6C, and PDE6H, all of which encode components of the cone phototransduction cascade.
2e5 CNGA3 and CNGB3 encode the a and b subunits of the cGMP-gated cation channel, respectively, and account for approximately 80% of cases of ACHM. 1, 2 Sequence variants in GNAT2, PDE6C, and PDE6H are uncommon causes of ACHM, each accounting for <2% of patients, and encode the a-subunit of transducin and the a and g subunits of cGMP phosphodiesterase, respectively. 3e5 There have been several optical coherence tomography (OCT)ebased studies that have investigated outer retinal architecture and foveal morphology in ACHM. 6e9 The macular appearances described include normal lamination, variable degrees of disruption of the hyperreflective photoreceptor bands (known as either the inner segment/outer segment [OS] junction or inner segment ellipsoid [ISe] ), an optically empty cavity or hyporeflective zone (HRZ), and complete outer retinal and RPE loss. 6e9 There are significant limitations to these studies, including the fact that subjects were not genotyped in all cases, and many relied on qualitative metrics to analyze the OCT images. In addition, there are conflicting data on progression and the presence or absence of age-dependent outer retinal loss, with Thiadens et al 6 and Thomas et al 7 suggesting age-associated progression, whereas Genead et al 8 provided evidence that cone loss is not age dependent. These inconsistencies, and the fact that several groups around the world are in preparation for gene replacement clinical trials, makes it critical to elucidate the progressive nature (and thus the therapeutic window) in ACHM in a genotype-dependent fashion.
Several studies have shown that gene therapy can be effective in restoring cone function in multiple animal models of ACHM. 10e14 In a Cngb3 À/À mouse model, subretinal gene delivery resulted in restoration of electrophysiologic function to near normal levels and significantly improved visual behavior, 13 with larger canine models of CNGB3-associated disease also showing increased electrophysiologic responses and improvements in navigational ability after gene replacement therapy. 14 In anticipation of the imminent human gene therapy trials for ACHM, we sought to characterize the relationship between retinal structure and function in a large number of molecularly proven subjects. This information is important to help identify the most suitable candidates for therapy, to determine the optimal timing for intervention, and to measure its impact using appropriate outcome measures.
Methods

Subjects
Forty subjects with a clinical diagnosis of ACHM were included in this study. Ten additional subjects with normal vision were recruited. The protocol of the study adhered to the tenets of the Declaration of Helsinki, was approved by the local Ethics Committees of Moorfields Eye Hospital and the Medical College of Wisconsin, and was performed with the informed consent of all subjects.
Clinical Assessments
All subjects underwent a clinical history and detailed ocular examination, including best-corrected visual acuity (BCVA) using an Early Treatment Diabetic Retinopathy Study chart, reading acuity using the MNRead chart, contrast sensitivity assessment using the Pelli-Robson chart at 1 m, color vision testing (Ishihara and Hardy Rand Rittler pseudoisochromatic plates), color fundus photography, spectral domain OCT (SD-OCT), and microperimetry (MP).
On the basis of their fundus appearance on color fundus photography, each subject was assigned to 1 of 3 categories: (1) no RPE disturbance, (2) RPE disturbance, or (3) atrophy. 
SD-OCT
For all subjects (80 eyes of 40 subjects), after pupillary dilation, line and volume scans were obtained using a Spectralis SD-OCT (Heidelberg Engineering, Heidelberg, Germany). The volume acquisition protocol consisted of 49 B-scans (124 mm between scans; 20Â20 ), with Automatic Real Time eye tracking used when possible. The lateral scale of each image was estimated using the axial length data obtained from the Zeiss IOL Master (Carl Zeiss Meditec, Jena Germany).
Qualitative Assessment of Foveal Morphology. Foveal structure on SD-OCT images was graded into 1 of 5 categories (Fig 1): (1) continuous ISe, (2) ISe disruption, (3) ISe absence, (4) presence of an HRZ, or (5) outer retinal atrophy, including RPE loss. The presence/absence of foveal hypoplasia was also noted, defined as the persistence of !1 inner retinal layers (outer plexiform layer, inner nuclear layer, inner plexiform layer, or ganglion cell layer) through the fovea. Figure 2 shows examples of the varying degrees of foveal hypoplasia observed in the subjects examined herein. Consensus grading was established by 3 independent examiners (V.S., J.C., and M.M.).
Quantitative Analysis of Photoreceptor Structure on SD-OCT. We used a method that was conceptually similar to that described by Hood et al 15 to analyze the intensity of the ISe and external limiting membrane (ELM) bands, although there are a number of differences. First, our images were transformed into a linear display using a transform provided by the manufacturer. This is a critical correction to apply, because the native visualization of SD-OCT images on a logarithmic scale misrepresents the real differences in reflectivity (Fig 3) . Second, we assessed layer intensity at only 2 specific retinal locations, 1 and 1.5 mm temporal to the fovea (because of the outer retinal disruption in many subjects, 1 mm was the closest eccentricity we could measure in all subjects). Finally, the procedure used to measure layer intensity was different. We generated longitudinal reflectivity profiles 16 at the 1-and 1.5-mm locations, and each longitudinal reflectivity profile was 5 pixels in width (Fig 3) . Hood et al 15 defined a "local region" surrounding a specific segment of the ISe as extending AE275 mm to either side of the ISe segment and extending axially between the Bruch's membrane/choroid interface and the posterior border of the retinal nerve fiber layer. 15 Because other posterior layers may be altered because of the disruption in cone structure, including the outer nuclear layer (ONL) and Henle fiber layer, or the layers posterior to the ISe that are thought to originate from interactions between the photoreceptors and RPE, 17 we used a "local region" restricted to the retinal ganglion cell layer and inner plexiform layer. This is indicated by the horizontal arrows in Figure 3 . We then measured the peak image intensity at the ELM and ISe (labeled in Fig 3) , and the relative intensity of the ISe (or ELM) was taken as the ISe (or ELM) peak intensity divided by the average intensity in the "local region," generating the ISe (or ELM) intensity ratio used for analysis. Foveal hypoplasia was defined here as the persistence of !1 inner retinal layers (outer plexiform layer, inner nuclear layer, inner plexiform layer, or ganglion cell layer) through the foveal center. Normal retinal anatomy (top panel) shows complete excavation of the inner retinal layers at the fovea, resulting in the characteristic "pit." However, in a number of conditions (such as retinopathy of prematurity and albinism), this process is impaired ("foveal hypoplasia"), resulting in retinas in which the inner retinal layers persist at the fovea. Interestingly, this can also be seen in achromatopsia. The 3 lower panels show examples of varying degrees of foveal hypoplasia in patients with achromatopsia, in whom the fovea contains inner retinal layers as opposed to complete excavation of these layers. Twenty-one of the 40 subjects (52.5%) had foveal hypoplasia, although it was not possible to assess hypoplasia in 2 subjects because of severe foveal atrophy. There was no difference in age, contrast sensitivity, retinal sensitivity, or fixation stability between subjects with or without foveal hypoplasia (see text). In addition to examining the ELM and inner segment/OS intensity, we measured the total retinal thickness (internal limiting membrane to RPE distance) and ONL thickness (ILM to ELM distance) at the fovea. In cases of foveal hypoplasia, the distance between the posterior outer plexiform layer boundary and the ELM was taken as the ONL thickness. All thickness measurements were conducted by a single observer (C.H.) using ImageJ software (National Institutes of Health, Bethesda, MD).
Microperimetry
MP was performed on both eyes of all subjects using the MP-1 microperimeter (Nidek Technologies, Padova, Italy). Specific details can be found in the online only material (Appendix 1, available at http://aaojournal.org). Fixation stability was assessed using the bivariate contour ellipse area (BCEA) which represents an area in degrees where 68% of fixation points are located; 18 this value is reported by the Nidek software.
Molecular Genetic Testing
Conventional direct Sanger sequencing of exons and exon-intron boundaries of CNGA3, CNGB3, GNAT2, and PDE6C was undertaken using previously published methods.
2e4 Subjects 39 and 40 also underwent screening of exons and exon-intron boundaries of PDE6H.
5
Statistical Analysis
Normality of data was assessed by evaluating the shape of histogram plots, with age, BCVA, contrast sensitivity, and reading acuity considered to be normally distributed. Intereye correlations for all parameters were assessed using Pearson or Spearman correlation analysis where appropriate. The left eye was arbitrarily selected for further analysis, and differences in parameters between SD-OCT categories, fundus appearance category, and genotype were assessed using 1-way analysis of variance or the KruskalWallis test where appropriate. Differences in parameters between subjects with or without foveal hypoplasia were assessed using either an independent samples t-test or ManneWhitney U test where appropriate.
Results
Twenty male and 20 female subjects with a mean age of 24.9 years (range, 6e52 years) were included (Tables 1 and 2 ). Mean BCVA was 0.92 logarithm of the minimum angle of resolution (range, 0.72e1.32), mean contrast sensitivity was 1.16 logCS (range, 0.50e1.55), and mean reading acuity was 0.76 logarithm minimum angle of resolution (range, 0.5e1.32; Table 2 ). There was no correlation between age and (1) BCVA (r ¼ 0.18; P ¼ 0.27; Fig 4) , (2) contrast sensitivity (r ¼ À0.27; P ¼ 0.09), or (3) reading acuity (r ¼ 0.29; P ¼ 0.07).
All subjects were able to read the Ishihara test plate, but were unable to read any subsequent plates or to correctly identify any of the Hardy Rand Rittler test plates.
Fundus examination revealed no evidence of macular RPE disturbance in 11 subjects (mean age, 19.5 years; range, 6e33 years) RPE disturbance in 20 subjects (mean age, 27.5 years; range, 12e52 years), and well-circumscribed macular atrophy in 9 subjects (mean age, 25.9 years; range, 11e43 years; Table 2 ). There was no difference in mean age, BCVA, contrast sensitivity, reading acuity, retinal sensitivity, or bivariate contour ellipse area between these 3 groups (Table 3 , available at http://aaojournal.org). Longitudinal reflectivity profile assessment of photoreceptor integrity on spectral domain optical coherence tomography (SD-OCT). The top image is the native display of the image from the SD-OCT, whereas the lower image is a linear display of the actual image intensity. Note that in the linear (raw) SD-OCT image, greater differences in layer intensity get compressed when visualized on a logarithmic display. Moreover, the logarithmic transform will increase the widths of the hyperreflective bands being measured. 17 This highlights the need to use raw SD-OCT data when making quantitative measures of layer intensity. Vertical lines in each image indicate the location of the longitudinal reflectivity profile (LRP) shown to the right of each image. Short horizontal arrows define the boundaries of the "local region" used to normalize the inner segment ellipsoid (ISe) or external limiting membrane (ELM) intensity. a.u. ¼ arbitrary units. Ophthalmology Volume 121, Number 1, January 2014
Molecular Genetics
Eighteen subjects (45%) had mutations in CNGA3 (mean age, 24.1 years; range, 7e49 years), 15 (37.5%) had mutations in CNGB3 (mean age, 20.4 years; range, 6e47 years), 4 (10%) had mutations in GNAT2 (mean age, 43.3 years; range, 29e52 years), and 1 subject had a mutation in PDE6C (Tables 1, 2 , and 4). Seven novel mutations were found in our group of 40 subjects (Table 4) . No likely disease-associated variants were identified in 2 individuals, which included screening for PDE6H mutations, in addition to these 4 genes. Detailed in silico analysis of both previously described and novel variants is shown in Table 4 .
2,19e22
Foveal Morphology
On the basis of SD-OCT imaging, subjects were placed into 1 of 5 categories (Fig 1) : (1) 9 Table 5 , available at http://aaojournal.org).
Of the nine subjects with macular atrophy on fundus examination, 3 subjects were in SD-OCT category 2, 2 in SD-OCT category 3, 1 in SD-OCT category 4, and 3 subjects in SD-OCT category 5. The proportion of subjects with any disruption in cone structure (SD-OCT categories 2e5) was consistent with previous studies. There were no differences in the age (P ¼ 0.77), BCVA (P ¼ 0.44), contrast sensitivity (P ¼ 0.57), or retinal sensitivity (P ¼ 0.21) between subjects in the 5 SD-OCT categories; however, reading acuity was significantly worse (P ¼ 0.02) in subjects with no ISe disruption compared with subjects with an HRZ (Table 5 ). Figure 5 shows representative SD-OCT images of subjects of different ages and genotypes, illustrating the variable appearances within different genotypes and the lack of age dependence on the integrity of outer retinal architecture.
Foveal hypoplasia was found in 21 subjects (52.5%) ( Table 1;  Table 6 , available at http://aaojournal.org), with it not being possible to assess hypoplasia in 2 subjects because of severe foveal atrophy. Our rate of hypoplasia was slightly lower than 2 previous reports, which used different definitions of hypoplasia than that used herein. 6, 7 There was no significant difference in age, contrast sensitivity, retinal sensitivity, or fixation stability between subjects with or without foveal hypoplasia. Surprisingly, BCVA (P < 0.01) and reading acuity (P < 0.01) were better in subjects with evidence of foveal hypoplasia compared with those without (Table 6 ).
ELM and ISe Intensity Ratios
The mean intensity ratios of the ISe band, measured at 1 and 1.5 mm from the fovea in the 40 ACHM subjects, were 1.73 (range, 0.80e4.65) and 1.82 (range, 0.67e4.96), respectively (Table 1) . These values were significantly lower compared with 10 controls with mean ISe ratios of 4.26 (range, 1.84e7.81; P < 0.001) at 1 mm from the fovea and 3.98 at 1.5 mm (range, 2.01e6.70; P < 0.001) from the fovea, although there was overlap between the range of intensity ratios observed in ACHM subjects and controls.
In contrast, the mean intensity ratios of the ELM band, measured at 1 and 1.5 mm from the fovea in the 40 ACHM subjects, were 0.66 (range, 0.32e1.40) and 0.68 (range, 0.35e1.18), respectively (Table 1) . These values were similar to those measured in 10 controls, with mean ELM intensity ratios of 0.69 (range, 0.39e1.01; P ¼ 0.47) at 1 mm from the fovea and 0.60 at 1.5 mm (range, 0.39e0.84; P ¼ 0.43) from the fovea.
No differences were found in ELM or ISe intensity ratios between CNGA3 and CNGB3 subjects, with the mean ELM intensity ratios at 1 and 1.5 mm from the fovea being 0.66 and 0.71 in CNGA3 subjects, and 0.68 and 0.68 in CNGB3 subjects, respectively (P ¼ 0.51 and P ¼ 0.80). The mean ISe intensity ratios at 1 and 1.5 mm from the fovea were 1.61 and 1.70 in CNGA3 subjects, and 1.61 and 1.56 in CNGB3 subjects, respectively (P > 0.99 and P ¼ 0.32).
Foveal ONL and Total Retinal Thickness
Mean foveal thickness and ONL thickness at the fovea in ACHM subjects was 163.6 mm (range, 62.0e313.2 mm) and 67.1 mm (range, 26.2e110.5 mm), respectively, which were significantly lower than mean foveal thickness (190.4 mm; range, 136.2e217.0 mm; P ¼ 0.02) and mean ONL thickness at the fovea (104.9 mm; range, 82.9e119.5 mm; P 0.001) in controls. Again, it is worth noting that there was overlap between the ACHM subjects and controls, consistent with the presence of retained cone nuclei in some ACHM subjects. No correlation was found between age and either foveal thickness (r ¼ 0.03; P ¼ 0.84) or foveal ONL thickness (r ¼ 0.26; P ¼ 0.12) in subjects with ACHM.
Microperimetry
All 40 subjects underwent MP testing on !2 occasions. There was no difference in mean retinal sensitivity and fixation stability between eyes, and further analysis was therefore performed using the left eye only in each subject. No difference in mean retinal sensitivity or fixation stability was found between subjects' first and second test; the mean of these 2 tests was used for subsequent analysis.
The mean retinal sensitivity of the group was 16.6 dB (range, 3.1e19.9 dB), and the mean fixation stability of the group was 13.5 (range, 1.7e65 ), with significant negative correlations found between retinal sensitivity and (1) age (r ¼ À0.39; P ¼ 0.01; Fig 6) , (2) BCVA (r ¼ À0.44; P < 0.01; Fig 7) , and (3) reading acuity (r ¼ À0.55; P < 0.01). Surprisingly, a significant correlation was found between lower contrast sensitivity and both higher retinal sensitivity (r ¼ 0.35; P ¼ 0.03) and higher fixation stability (r ¼ À0.43; P < 0.01). There was no difference in mean retinal sensitivity (P ¼ 0.21) or fixation stability (P ¼ 0.34) across the 5 SD-OCT categories (Table 5 ). There was a significant correlation between fixation stability and BCVA (r ¼ 0.43; P < 0.01).
ELM ¼ external limiting membrane; ISe ¼ inner segment ellipsoid; F ¼ female; M ¼ male; N/A ¼ not possible to assess due to presence of outer retinal atrophy; No ¼ number; ND ¼ no mutation detected; Pt. ¼ patient; SD-OCT ¼ spectral domain optical coherence tomography. The cDNA is numbered according to Ensembl transcript ID: CNGA3 ENST00000409937; CNGB3 ENST00000320005; GNAT2 ENST00000351050; PDE6C ENST00000371447, in which þ1 is the A of the translation start codon. Six subjects had a scotoma (0 dB sensitivity in !1 location), with a mean sensitivity in this group of 11.0 dB (range, 3.1e14.8 dB), and mean fixation stability of 12.8 (range, 1.7e24 ). The mean age of these subjects was 40.2 years (range, 25e52 years) and mean BCVA was 1.01 logarithm of the minimum angle of resolution (range, 0.8e1.32). Four of these 6 subjects had RPE disturbance on fundus examination, with the remaining 2 subjects having macular atrophy. It is of note that variable macular structure was seen on SD-OCT, with 3 of the 6 subjects having a normal ISe layer, and 1 subject each having an absent foveal ISe layer, or HRZ, or outer retinal atrophy.
GenotypeePhenotype Correlation
The vast majority (82.5%) of subjects in our study had either CNGA3 or CNGB3 mutations. There were no differences between the subjects with these 2 genotypes in terms of age, BCVA, contrast sensitivity, reading acuity, or fixation stability (Table 7 , available at http://aaojournal.org). However, retinal sensitivity was significantly greater in the CNGB3 group than in the CNGA3 group (18.1 vs 16.1 dB; P ¼ 0.04).
A comparison of the SD-OCT phenotypes and presence of foveal hypoplasia failed to identify any consistent differences between the CNGA3 and CNGB3 subjects. Specifically, 26.7% of subjects (n ¼ 4) with CNGB3 mutations had no ISe disruption, compared with 11.1% (n ¼ 2) with CNGA3 variants; 20% (n ¼ 3) harboring CNGB3 variants had ISe disruption compared with 44.4% (n ¼ 8) in the CNGA3 group (Table 7) . The presence of an HRZ was similar in CNGA3 (n ¼ 4; 22.5%) and CNGB3 (n ¼ 4; 26.7%) subjects. Outer retinal atrophy was observed in 13.3% (n ¼ 2) of CNGB3 subjects compared with 5.5% (n ¼ 1) of CNGA3 subjects. In the CNGA3 group, 61% of subjects (n ¼ 11) had foveal hypoplasia, compared with 53% of CNGB3 subjects (n ¼ 8). Foveal hypoplasia was not present in the 4 subjects with GNAT2 mutations or in the single PDE6C subject.
On examination, 44.4% of CNGA3 subjects (n ¼ 7) had a normal fundus appearance, compared with 20% (n ¼ 3) in the CNGB3 group; 33.3% of CNGA3 subjects (n ¼ 6) had RPE disturbance compared with 53% of subjects with CNGB3 variants (n ¼ 8). The percentage of subjects with macular atrophy was similar in both groups (CNGA3, 22.3% [n ¼ 4]; CNGB3, 27% [n ¼ 4]). Of the 6 subjects with a scotoma on MP, 4 had GNAT2 variants, 1 had PDE6C variants, and 1 had CNGA3 variants. In addition, BCVA, contrast sensitivity, reading acuity, and mean sensitivity were lower in the GNAT2 and PDE6C genotypes, compared with the CNGA3 or CNGB3 groups; however, the mean age of subjects with either GNAT2 or PDE6C mutations was considerably higher than the CNGA3/CNGB3 group (Table 7) . Interestingly, 3 out of the 4 subjects with GNAT2 mutations had an intact ISe layer, despite a relatively low mean retinal sensitivity of 13.6 dB, with all of these subjects having a central scotoma on MP.
Discussion
Lack of Age Dependence of Cone Loss
Our cross-sectional study (n ¼ 40) identified no agedependent loss of cone structure in subjects with ACHM. For example, we found that cone loss (SD-OCT categories 3e5) was evident in approximately 57% of subjects (16/28) <30 years of age, but in only 33% (4/12) aged >30 years. Moreover, subjects without ISe disruption (most preserved cone structure) had the second greatest mean age of the 5 SD-OCT categories; no reduction in ISe intensity was found with advancing age. In addition, foveal ONL and total retinal thickness was significantly reduced, although we did not find an association between retinal thinning and advancing age. In contrast with our findings, Thiadens et al 6 reported that cone loss occurred in 42% of affected individuals (8/19) who were <30 years of age, with 95% (20/21) >30 years old showing cone loss on SD-OCT. 6 Thomas et al 7 also reported age-dependent ONL thinning. 7 One possible explanation for this discrepancy is the lack of standardization of how cone loss is measured. Moving forward, it will be important to conduct larger studies with molecularly proven subjects in which the same anatomic measures are undertaken. Although our study demonstrates that outer retinal changes do not necessarily occur in a predictable, agedependent manner, a recent small (n ¼ 8), longitudinal study observed progressive changes in retinal morphology in younger but not older patients. 23 However, bearing in mind the characteristic phenotypic variability of inherited retinal disease, longitudinal studies are needed to examine the progressive nature of ACHM. It is Figure 5 . Variable spectral domain optical coherence tomography (SD-OCT) appearance in subjects of various ages and genotypes. Representative SD-OCT images of subjects of different ages and genotypes, illustrating the variable appearances within different genotypes and the lack of age dependence on the integrity of outer retinal architecture.
important to note that progression does not imply that age alone should be a principal eligibility criterion for emerging trials, as different patients likely progress at different rates.
Retinal Function
We identified no correlation of deterioration in BCVA, contrast sensitivity, or reading acuity with advancing age, and to the best our knowledge, this is the largest study to date reporting any potential change in these parameters with age. We did, however, find a decline in MP-based retinal sensitivity with age. A significant reduction in retinal sensitivity, determined by mesopic MP, has been reported to occur in normal subjects with increasing age, with a 1-dB lower retinal sensitivity found in subjects aged 70 to 75 years compared with those aged 20 to 29 years. 24 In our study, the decline in sensitivity of 3.1 dB observed between subjects <25 years of age (n ¼ 22) and those >25 years old (n ¼ 18) is greater than that potentially attributable to age-related decline.
In our cohort of subjects with absent cone function (on the basis of electrophysiology and psychophysics), it is presumed that retinal sensitivity detected by mesopic MP testing is a consequence of retained rod function. This raises the question as to whether rod function declines in subjects with ACHM with age and if so, why? If there is no change in rod function, it remains a possibility that there is residual central cone function in some subjects, which may deteriorate over time. Further investigation is required to determine which class of photoreceptor(s) is responsible for the retinal sensitivity detected by mesopic MP in ACHM. For example, measuring the rate of recovery of retinal sensitivity using the microperimeter after a full bleach might help to shed light on this intriguing issue.
StructureeFunction Relationships
We identified no clear association between retinal structure and function, with no differences in BCVA, contrast sensitivity, retinal sensitivity, or fixation stability between subjects with the various SD-OCT findings or fundus changes. This is in keeping with the lack of an association reported between the presence of an HRZ and visual acuity in previous studies. 6, 7 Surprisingly, subjects without ISe disruption had a significantly lower (P ¼ 0.02) reading acuity compared with subjects with HRZ presence; however, a statistical difference was not found in any other functional parameter, suggesting this is not a clinically significant observation. No correlation was found between ISe intensity and retinal sensitivity, although this is perhaps to be expected; in the absence of cone function, retinal sensitivity is likely to be primarily derived from rod function in ACHM subjects.
We found no differences in contrast sensitivity, retinal sensitivity, or fixation stability in subjects with or without foveal hypoplasia; however, surprisingly, significantly better BCVA and reading acuity were found in subjects Figure 6 . Negative correlation between age and retinal sensitivity. All 40 subjects underwent microperimetry testing on !2 occasions. There was no difference in mean retinal sensitivity between both eyes, and further analysis was therefore performed using the left eye only. No difference in mean retinal sensitivity was found between subjects' first and second tests, and the mean of these 2 tests was used for subsequent analysis. The mean retinal sensitivity of the group was 16.6 decibels (range, 3.1e19.9), with significant negative correlation found between retinal sensitivity and age (r ¼ À0.39; P ¼ 0.01). Acuity is reported as logarithm minimum angle of resolution (logMAR). dB ¼ decibels. Figure 7 . Negative correlation between visual acuity and retinal sensitivity. The mean retinal sensitivity of the cohort was 16.6 decibels (dB) (range, 3.1e19.9 dB) with significant negative correlation found between retinal sensitivity and visual acuity (r ¼ À0.44; P < 0.01). logMAR ¼ logarithm minimum angle of resolution.
with foveal hypoplasia. This is reminiscent of findings in albinism, where the absence of a fovea does not necessarily impair acuity. 25, 26 However, a structural grading system for foveal hypoplasia reported by Thomas et al 27 has suggested a relationship between foveal development and acuity. It is also likely that varying degrees of nystagmus amplitude or frequency between subjects contribute to determining BCVA and retinal sensitivity in ACHM and other disorders.
Implications for Gene Therapy
Gene replacement trials for both CNGA3 and CNGB3 are planned in the near future. Our findings of no age dependence of cone loss demonstrate that the potential window of opportunity for therapeutic intervention in ACHM is wider than has previously been suggested; subjects with no evidence of ISe disruption were aged between 6 and 52 years and we found no correlation of cone photoreceptor disruption or loss with increasing age.
Because this was a cross-sectional study, it has not assessed whether subjects who have any form of outer retinal change develop progressive degeneration, and, if so, how variable the rate of change may be. With respect to cone photoreceptor structure, we therefore suggest that candidates should be considered for potential gene therapy intervention on an individual basis, irrespective of their age. In addition, we did not observe decreased visual function in subjects with foveal hypoplasia; in fact, significantly better BCVA and reading acuity were found in subjects with foveal hypoplasia, suggesting that foveal hypoplasia per se should not be an exclusion criterion for potential therapy trials. In the 9 subjects with no ISe disruption evident on SD-OCT, their mean ISe intensity ratio was considerably lower than in healthy controls, illustrating that assessment of the degree of residual cone structure using this metric may be useful in determining the suitability of potential trial participants. Direct visualization of the cone mosaic is afforded through the use of adaptive optics imaging. There is a need to elucidate the relationship between these various measures of cone structure in ACHM to establish the most appropriate means to identify suitable patients and track therapeutic efficacy.
In addition to cone photoreceptor integrity, another factor likely to influence the response to gene therapy is the ability of the visual system to respond to newly acquired input. Functional magnetic resonance imaging has shown evidence of visual cortex reorganization in ACHM subjects, with the area of visual cortex normally active after cone-derived foveal stimulation being active instead after rod stimuli. 31 Conversely, recovery of cone-driven cortical activity has been observed in a canine model of ACHM (Gingras G. Cortical recovery following gene therapy in a canine model of achromatopsia. Paper presented at: The Vision Sciences Society Meeting, May 8, 2009; Florida) . The extent to which the visual cortex is able to adapt to and process new input from cone photoreceptors is an additional consideration likely to influence the efficacy of gene replacement therapy.
